[New combination medications].
Agosto
M
M
National Minority AIDS Council, Washington, DC.
D019380:Anti-HIV Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D020008:Delavirdine; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007211:Indoles / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D007546:Isoquinolines / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D019888:Nelfinavir; D019829:Nevirapine; D010879:Piperazines / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D011725:Pyridines / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D013451:Sulfonic Acids / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D007211:Indoles; D007546:Isoquinolines; D010879:Piperazines; D011725:Pyridines; D018894:Reverse Transcriptase Inhibitors; D013451:Sulfonic Acids; D019829:Nevirapine; D020008:Delavirdine; D019888:Nelfinavir